Overview

Darktrace is the world’s fastest growing cyber security company and the global leader in immune system technology. Our radically new approach, the Enterprise Immune System, uses unsupervised machine learning and probabilistic mathematics to understand a network’s ‘pattern of life’ and thus to detect anomalous activity as it arises. Since its foundation in 2013, Darktrace has experienced phenomenal growth, a testament to the global demand for our innovative machine learning technology and its success on the market.

With a 615% year-on-year revenue increase from 2015 to 2016 and a 240% booking increase in the last fiscal year, Darktrace is rapidly expanding its 350+ customer base. Deployed over 1,300 times globally within just three years, the Enterprise Immune System has been adopted by diverse organizations that span all industry verticals. Our customer base ranges from large companies, such as T-Mobile and DirecTV, to small and medium enterprises.

Darktrace has become a global leader in an intensely competitive cyber security space. In May 2016, Nicole Eagan, CEO, accompanied the US Embassy on their official trade mission to Asia, where Darktrace later secured a partnership with Samsung SDS. The company has also recently expanded into India and Latin America. In July, Darktrace gained $65 million in Series C funding from KKR, a private equity pioneer, to drive further global expansion.

This growth continues into Darktrace’s product suite as well—immune system technology is now available for SaaS and cloud environments, as well as for Industrial Control Systems. Darktrace’s dedication to expanding the frontiers of cyber security and looking toward future innovation is perhaps best exemplified by its latest product release: Antigena, a ground-breaking new technology that allows networks to automatically self-defend.

Named a Technology Pioneer by the World Economic Forum, Darktrace is redefining an industry while rapidly growing as a company.